GW4064 also inhibits tumor growth of human ER+ BC cells co-injected with CAFs in a mouse model in vivo, with tumors exhibiting decreased levels of leptin-regulated proteins and a strong staining intensity for SOCS3 [542]. This evidence concerns the gene LEP and breast cancer.